Meyka Pro banner
Absci Corporation

Absci Corporation (ABSI) Stock Overview

Explore Absci Corporation’s financial performance, market position, analyst ratings, and future outlook.

ABSINASDAQ
HealthcareBiotechnology
$9.63
$0.79(8.94%)
U.S. Market opens in 13h 25m

Absci Corporation (ABSI)

Meyka AI Score

Z

Key Financials

Market Cap1.6B
P/E Ratio-12.06
EPS (TTM)$-0.80
ROE-0.59%
Fundamental Analysis

AI Price Forecasts

1 Month$9.98
3 Months$12.53
1 Year Target$5.84

ABSI Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Absci Corporation (NASDAQ: ABSI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Absci Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ABSI on the NASDAQ shows an RSI of 56.18, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $5.84 for the NASDAQ listing.

Key metrics behind Absci Corporation's NASDAQ-traded stock include a P/E ratio of -12.06 and a market capitalization of 1.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ABSI on the NASDAQ.

Price Performance (NASDAQ: ABSI)

1-Day Change
8.94%
5-Day Change
-1.13%
1-Month Change
27.38%
3-Month Change
82.39%
6-Month Change
251.46%
Year-to-Date (YTD) Change
175.93%
1-Year Change
279.13%
3-Year Change
473.21%
5-Year Change
-51.49%
All-Time (Max) Change
-55.40%

Contact Information

360 949 1041
18105 SE Mill Plain Boulevard, Vancouver, WA, 98683

Company Facts

1,400 Employees
IPO DateJul 22, 2021
CountryUS
Actively Trading

Frequently Asked Questions